We develop novel single cell proteomic approaches, and combine them with tumor analyses and bioinformatics to characterize the cellular interactions within the tumor microenvironment, and how these interactions associate with response to immunotherapy.

This page includes a list of publications for the research carried out in Prof. Tamar Geiger

T Geiger, J Cox, P Ostasiewicz, JR Wisniewski, M Mann. Nature methods 7 (5), 383-385, 2010. 669: 2010: Defining the transcriptome and proteome in three functionally different human cell lines.

Prof. Tamar Geiger. Weizmann Institute of Science Rehovot 76100, ISRAEL Wolfson Building for Biological Research Room 162. Tel: +972-8-934-6790 [email protected]

Dive into the research topics where Tamar Geiger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Tami Geiger is an expert in clinical cancer proteomics. She completed her M.Sc. and Ph.D. in biochemistry at the Hebrew University of Jerusalem. Then she moved to the laboratory of Prof. Matthias Mann at the Max Planck Institute of Biochemistry to specialize in proteomics technology and apply it to cancer research.

Electronic address: [email protected]. Comprehensive molecular characterization of tumors aims to uncover cancer vulnerabilities, drug resistance mechanisms and biomarkers.

Prof Tami Geiger from the Weizmann Institute of Science, is a world leader in clinical cancer proteomics. Her lab uses state of the art mass spectrometry-based proteomics technology to study cancer progression and drug resistance mechanisms. Her research combines proteomic method development with basic biological research and bioinformatics.

Multilayered tumor investigation provides the necessary perspective on cancer development and regulation. Prof. Tamar Geiger carries out research on various subject. This page gives an …